Semaglutide Making You Itchy? Here's What the Evidence Says

Injection-site itching is the most common skin reaction with semaglutide, typically settling within a few days of each dose.
A generalised itch across the body (pruritus) is reported less often but is documented in post-marketing data collected by the MHRA.
Severe itching alongside hives, swelling of the face or throat, or difficulty breathing may signal a serious allergic reaction — treat as a medical emergency.
Yellow Card lets patients report suspected skin reactions directly to the MHRA at yellowcard.mhra.gov.uk, which helps build the UK safety picture.

Itching is a recognised side effect of semaglutide, the active ingredient in Wegovy. It can appear as a localised reaction at the injection site, a more generalised skin sensation, or, in rarer cases, part of a broader allergic response. Most people who notice itching find it mild and temporary, but knowing what to watch for matters. These are prescription-only medicines, and any persistent or severe skin reaction is worth discussing with the clinician who prescribed them — semaglutide works differently for different people, and your prescriber can help distinguish a minor nuisance from something that needs attention.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding semaglutide-related itching: causes, patterns and when to act

A few days after your first injection, you notice your arm is itchy

It tends to start there, a patch of redness or a prickling sensation around the spot where the pen met skin. Injection-site reactions like this are among the more commonly reported effects of subcutaneous GLP-1 medicines, and semaglutide is no exception. The needle creates a small localised response as the body registers the injection; rotating sites between your abdomen, thigh and upper arm each week can reduce the likelihood of this building up in one area. For most people the itch fades on its own within a day or two, well before the next weekly dose is due. If the site becomes noticeably swollen, warm to the touch, or the irritation doesn't settle, it's worth mentioning at your next clinical check-in rather than waiting. The broader question of itchy skin on Wegovy covers what the data show across the Wegovy-specific clinical programme, including findings beyond the injection site.

Letting the pen reach room temperature for roughly thirty minutes before injecting (something easy to build into a morning routine, like leaving it out while you shower) can take the edge off localised stinging and may reduce the local skin response for some people. The Patient Information Leaflet that comes with your prescription sets out injection technique in full; that guidance takes priority over any general advice.

When the itch isn't just where the needle went

Some people on semaglutide report itching that has nothing to do with the injection site, a general prickling across the skin, sometimes called pruritus. This appears in post-marketing safety data and is listed as an uncommon effect in the prescribing documentation. The detailed look at whether semaglutide can cause itchy skin explores the proposed mechanisms, including the possibility that slowed gastric emptying and changes in bile-acid metabolism may contribute to skin sensations in some individuals, though the research here is still developing. For a smaller number of people, itchy eyes alongside other symptoms have also been reported, which can sometimes point to an allergic component worth assessing.

Generalised itching that arrives after a dose increase and then settles is a different clinical picture from itching that persists or worsens week on week. If yours fits the latter pattern, document when it started, whether it correlates with dose changes, and whether antihistamines give any relief, that information helps a prescriber assess what's going on. Our frequently asked questions cover a range of side-effect scenarios, and our clinical team is available seven days a week for aftercare queries.

Itching as a warning sign: recognising a serious allergic reaction

This is the part that needs to be said clearly. Severe itching is one of the early features of a serious hypersensitivity reaction, and semaglutide, like all medicines, carries a small risk of this. The pattern to watch for is itch or hives appearing alongside swelling of the lips, face, tongue or throat, difficulty breathing, a rapid heartbeat, or a sudden drop in blood pressure. If these occur together after an injection, call 999 and do not take the next dose until you have spoken to a doctor. The NHS semaglutide medicines page lists the signs of a serious reaction and advises stopping the medicine immediately. This scenario is rare; it is also time-critical.

Milder allergic skin reactions (hives without the systemic features above) should still be reported to your prescriber. They may recommend antihistamines short-term, observe whether the reaction recurs at the next dose, or in some cases reassess whether semaglutide is the right choice for you. The decision always sits with the clinician, not a self-managed protocol. You can also report any suspected reaction directly via the MHRA's Yellow Card scheme, which feeds into ongoing UK safety monitoring for GLP-1 medicines.

What to do if itching is affecting your treatment

Most itching on semaglutide doesn't require stopping the medicine. It requires assessment. If the reaction is localised and mild, rotating injection sites, adjusting technique, and keeping a simple symptom log are reasonable first steps. If it's generalised and persistent, a conversation with your prescriber may result in a temporary pause, a dose review, or investigation of whether something else is contributing (other medicines, seasonal allergies, skin conditions) since attributing everything to semaglutide when another cause is at play helps nobody. Information on what Wegovy costs, including what's included in a private prescription service, is on our Wegovy cost page, for anyone weighing up the full picture of private treatment.

At nume, every repeat order is reviewed by a GPhC-registered Independent Prescriber before it is dispensed. A prescriber reads your notes, not a queuing system. If you've been experiencing itching and aren't sure whether it warrants concern, that review is the right moment to raise it. The question of whether semaglutide can make you itchy is one our prescribers hear regularly, and the answer is always individual. If you're thinking about starting treatment and want to understand how clinical suitability is assessed, you can start a free consultation with our team.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions